Chardan Analyst: Amicus Therapeutics Could Be Bought For $22.50/Share By: Benzinga via Benzinga April 12, 2016 at 09:44 AM EDT Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) climbed 7 percent in the pre-market hours after a Wall Street analyst said the ... Read More >> Related Stocks: Amicus Therapeutics Biomarin Pharmaceuticals Ionis Pharmaceuticals Macy's Sanofi-Aventis S.A. ADR Shire Plc Ads Ultragenyx Pharmaceu